• Nenhum resultado encontrado

Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.

N/A
N/A
Protected

Academic year: 2017

Share "Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort."

Copied!
9
0
0

Texto

Loading

Imagem

Table 1. Characteristics of study population.
Figure 2. Long-term survival by etiology. The median survival was significantly longer in HCV-related HCC patients than in HBV-related HCC patients
Table 4. Adjusted difference in the survival between hepatitis B virus and hepatitis C virus related hepatocellular carcinoma by subgroup.

Referências

Documentos relacionados

HIV: human immunodefi ciency virus; HCV: hepatitis C virus; HBV: hepatitis B virus; STD: sexually transmitted diseases; HBV+§: Hepatitis B virus active or past infection

This study was carried out to determine the prev- alence of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers among adolescents aged between 10 and 16 years old, who

We investigated the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) serological markers of infection in young adults from the metropolitan region of Florianópolis

Infection with hepatitis C virus (HCV) affects millions of individuals in the world, resulting in chronic liver disease like chronic hepatitis (CH) and hepatocellular carcinoma

The patient has no conditions classically associated with the development of hepatocellular carcinoma (virus infection of hepatitis B and hepatitis C, alcoholism,

A survey was conducted in the hemodialysis population of the state of Tocantins, Brazil, aiming to assess the prevalence of hepatitis B virus (HBV) and hepatitis C virus

Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.

The aim of this study was to estimate the serop- revalence rates of human immunodeficiency vi- rus (HIV), hepatitis B virus (HBV, core antibody), hepatitis C virus (HCV), and